School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

NEUROCRINE BIOSCIENCES INC NBIX

Healthcare · Drug Manufacturers - Specialty & Generic

$142.44last close 2026-10-09 · market cap $14.48B · delayed data

Trailing returns

1M-8.19%
3M-21.11%
6M+8.20%
1Y+2.87%
5Y+36.86%

Basis: Adjusted daily closes.

What it does

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Open NBIX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies